Tarik Tihan, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Tarik Tihan, MD, PhD

Associate Professor, Department of Pathology, UCSF

Phone: (415) 476-5236 (appts)
Box 0511, UCSF
San Francisco, CA 94143-0511

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Neurologic Oncology

Education

University of Istanbul, School of Medicine, MD, 1979-85, Medicine
University of Istanbul/Univ. Of Vienna, PhD, 1986-89, Biochemistry


Professional Experience

  • 1985-1986
    Kahramanmaras State Hospital, Department of Critical Care, Turkey. House Officer.
  • 1986-1989
    University of Istanbul, Istanbul Medical School, Department of Clinical Biochemistry. Clinical Instructor and Research Assistant.
  • 1988-1989
    University of Vienna, Department of Medical Chemistry, Austria. Research Assistant. Research Grant from the Austrian government, Ministry of Education, (Bundesministerium fuer Auswaertige Angelegenheiten).
  • 1989
    Doctorate, University of Istanbul, Department of Clinical Biochemistry. Diplomate of the Ministry of Health and Social Aid for the medical doctorate in Clinical Biochemistry.
  • 1989-1990
    University of South Florida, Department of Internal Medicine & H. Lee Moffitt Cancer Center. Research Associate.
  • 1991-1992
    Beth Israel Medical Center, Department of Neurosurgery. Manager of the Recanati Research Laboratory.
  • 1992-1994
    Beth Israel Medical Center, Department of Pathology, Resident
  • 1994-1995
    Memorial Sloan-Kettering Cancer Center, Department of Pathology. Fellow in Oncologic Pathology.
  • 1996
    American Board of Pathology Certificate of Anatomic Pathology.
  • 1995-1997
    State University of New York at Stony Brook, Department of Pathology. Fellow in Neuropathology.
  • 1997-2000
    Johns Hopkins Medical Institutions, Department of Pathology, Clinical Instructor. Johns Hopkins Bayview Medical Center, Department of Pathology. Attending Pathologist in Anatomic Pathology and Cytopathology.
  • 2000-2002
    Johns Hopkins Medical Institutions, Department of Pathology, Assistant Professor
  • 2002-present
    UCSF School of Medicine, Department of Pathology, Neuropathology Unit, Associate Professor
  • 2002-present
    Principal Investigator, Brain Tumor Research Center, Department of Neurological Surgery

Honors & Awards

  • 2001-2003
    John Hopkins W. Barry Wood Jr, Award in excellence in teaching
  • 2003
    USCF Department of Pathology Teaching Excellence Award
  • 2003, 2005
    UCSF Department of Neurological Surgery Teaching Excellence in Basic Science Award

Selected Publications

  1. The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016 Jan 15; 183(2):85-91.
    View on PubMed
  2. Surgical management of medically refractory epilepsy in patients with polymicrogyria. Epilepsia. 2016 Jan; 57(1):151-61.
    View on PubMed
  3. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015 Dec 4.
    View on PubMed
  4. Association of tumor location, extent of resection, and ncurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors. Neurosurg Focus. 2015 Aug; 39(2):E5.
    View on PubMed
  5. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol. 2015 Sep; 130(3):441-3.
    View on PubMed
  6. Surgical Management of Intracranial Neuroenteric Cysts: The UCSF Experience. J Neurol Surg B Skull Base. 2015 Dec; 76(6):475-9.
    View on PubMed
  7. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372(26):2499-508.
    View on PubMed
  8. Diagnosing Encephalitis, Not Otherwise Specified-Reply. JAMA Neurol. 2015 Jun 1; 72(6):726-7.
    View on PubMed
  9. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype. Clin Cancer Res. 2015 Aug 15; 21(16):3750-8.
    View on PubMed
  10. Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery. 2015 May; 76(5):592-600.
    View on PubMed
  11. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet Oncol. 2015 May; 16(5):569-82.
    View on PubMed
  12. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol. 2015 Apr; 129(4):609-10.
    View on PubMed
  13. Pathologic approach to spinal cord infections. Neuroimaging Clin N Am. 2015 May; 25(2):163-72.
    View on PubMed
  14. Encephalitis of unclear origin diagnosed by brain biopsy : a diagnostic challenge. JAMA Neurol. 2015 Jan 1; 72(1):66-72.
    View on PubMed
  15. Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution. Clin Neuropathol. 2015 Jan-Feb; 34(1):26-33.
    View on PubMed
  16. Practical issues in diagnostic neuropathology: it is not even the end of the beginning! Surg Pathol Clin. 2015 Mar; 8(1):ix-x.
    View on PubMed
  17. Practical molecular pathology and histopathology of embryonal tumors. Surg Pathol Clin. 2015 Mar; 8(1):73-88.
    View on PubMed
  18. Therapeutic targets in pilocytic astrocytoma based on genetic analysis. Semin Pediatr Neurol. 2015 Mar; 22(1):23-7.
    View on PubMed
  19. The basics of intraoperative diagnosis in neuropathology. Surg Pathol Clin. 2015 Mar; 8(1):27-47.
    View on PubMed
  20. Practical neuroimaging of central nervous system tumors for surgical pathologists. Surg Pathol Clin. 2015 Mar; 8(1):1-26.
    View on PubMed

Go to UCSF Profiles, powered by CTSI